A SERS quenching method for the sensitive determination of insulin

Drug Test Anal. 2021 May;13(5):1048-1053. doi: 10.1002/dta.2808. Epub 2020 May 25.

Abstract

In this work, we utilise the disulphide bond structure of insulin and a new benzothiazole Raman probe for the detection of human insulin using surface-enhanced Raman spectroscopy (SERS). The disulphide bond structure of the insulin was reduced to generate free sulfhydryl terminal groups. When reacted with benzothiazole-functionalised gold nanoparticles, the reduced protein desorbs the Raman probe and causes its Raman signal intensity to quench. Using this approach, insulin was quantified in the concentration range of 1 × 10-14 -1 × 10-8 M by SERS quenching. The limit of quantification of insulin by the SERS quenching method was found to be 1 × 10-14 M (0.01 pM or 58 pg/L), which satisfies the requirements for monitoring its blood concentration in patients. Because many proteins and peptides have disulphide bonds in their molecular structures, the new SERS quenching method has a strong potential for the rapid determination of ultralow concentrations of proteins in formulations and biological fluids.

Keywords: SERS quenching; benzothiazole Raman probe; disulphide bond structure; insulin; proteins.

MeSH terms

  • Benzothiazoles / chemistry
  • Disulfides / blood*
  • Disulfides / chemistry
  • Gold / chemistry
  • Humans
  • Insulin / blood*
  • Insulin / chemistry
  • Metal Nanoparticles / chemistry
  • Oxidation-Reduction
  • Protein Conformation
  • Reproducibility of Results
  • Spectrum Analysis, Raman*

Substances

  • Benzothiazoles
  • Disulfides
  • Insulin
  • Gold
  • benzothiazole